Transcription of Practical risk-based guide for managing data integrity
{{id}} {{{paragraph}}}
1. ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE. Practical risk-based guide for managing data integrity Version 1, March 2019. 2. PREAMBLE. This original version of this guidance document has been compiled by a subdivision of the APIC Data integrity Task Force on behalf of the Active Pharmaceutical Ingredient Committee (APIC) of CEFIC. The Task Force members are: Charles Gibbons, AbbVie, Ireland Danny De Scheemaecker, Janssen Pharmaceutica NV. Rob De Proost, Janssen Pharmaceutica NV. Dieter Vanderlinden, Ajinomoto Omnichem Andr van der Biezen, Aspen Oss Sebastian Fuchs, Tereos Daniel Davies, Lonza AG. Fraser Strachan, DSM. Bjorn Van Krevelen, Janssen Pharmaceutica NV.
Practical risk-based guide for managing data integrity Version 1, March 2019 . 2 PREAMBLE ... Achieving data integrity compliance, for paper, electronic and hybrid systems, requires translation of these principles into practical controls in order to assure GxP- impacting business decisions can be verified and inspected throughout the data ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}